FIELD: medicine.
SUBSTANCE: examination is preceded by three cycles of serum freezing and thawing for 20 and 10 minutes respectively, mixture disintegration, agitation at 120 vibrations per minute for 30 minutes. That is followed by measuring apolipoprotein B, lipoprotein(a), a relation thereof, apolipoprotein A-I, total cholesterol, triacylglycerol, and a decrease of the relation of apolipoprotein B to lipoprotein(a) by 20% and more, apolipoprotein A-I by 30% and more, an increase of total cholesterol by 18% and more, triacylglycerol by 16% and more as compared to a reference shows progression of atherogenicity in ischemic heart disease.
EFFECT: method enables more effective assessment of progression of atherogenicity in ischemic heart disease.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2013 |
|
RU2517054C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN LIPIDEMIA | 2011 |
|
RU2462718C1 |
| DIAGNOSTIC TECHNIQUE FOR LIPIDEMIA | 2011 |
|
RU2476888C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2520755C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2507518C1 |
| METHOD FOR DIAGNOSING LIPIDEMIA | 2019 |
|
RU2694531C1 |
| DIAGNOSTIC TECHNIQUE FOR EARLY AND LATE STAGES OF LIPIDEMIA | 2019 |
|
RU2694538C1 |
| METHOD FOR ASSESSING THE EFFECTIVENESS OF THE TREATMENT OF LIPIDEMIA | 2019 |
|
RU2694534C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2019 |
|
RU2714689C1 |
| METHOD FOR ASSESSING A POSSIBLE HIGH, MODERATE AND LOW RISK OF THROMBOGENIC COMPLICATIONS OF ISCHEMIC HEART DISEASE COURSE | 2019 |
|
RU2721877C1 |
